Published in Gut on March 01, 2002
Helicobacter pylori persistence: biology and disease. J Clin Invest (2004) 4.75
Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97
Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis (2008) 3.95
Helicobacter pylori in health and disease. Gastroenterology (2009) 3.84
Does Helicobacter pylori protect against asthma and allergy? Gut (2008) 2.67
Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One (2008) 2.04
East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage. Proc Natl Acad Sci U S A (2002) 1.92
Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis (2012) 1.84
Association between Helicobacter pylori and mortality in the NHANES III study. Gut (2013) 1.74
Exposure to Helicobacter pylori infection in early childhood and the risk of allergic disease and atopic sensitization: a longitudinal birth cohort study. Clin Exp Allergy (2014) 1.46
Concordance of Helicobacter pylori strains within families. J Clin Microbiol (2003) 1.22
Plasticity of repetitive DNA sequences within a bacterial (Type IV) secretion system component. J Exp Med (2003) 1.19
Transient and persistent Helicobacter pylori colonization in Native American children. J Clin Microbiol (2003) 1.14
Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J Clin Invest (2008) 1.09
Early-life family structure and microbially induced cancer risk. PLoS Med (2007) 1.06
Specific serum immunoglobulin G to H pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol (2007) 1.05
Consequences of Helicobacter pylori infection in children. World J Gastroenterol (2010) 1.03
Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter (2011) 1.02
Do you have a probiotic in your future? Microbes Infect (2008) 0.95
Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism. PLoS One (2012) 0.90
Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes (2013) 0.89
Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.87
Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol (2013) 0.86
Theodore E. Woodward Award: Global warming and the human stomach: microecology follows macroecology. Trans Am Clin Climatol Assoc (2005) 0.84
Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis (2013) 0.82
Role of childhood infection in the sequelae of H. pylori disease. Gut Microbes (2013) 0.80
Helicobacter pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years. Dig Dis Sci (2008) 0.80
Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens. J Infect Dis (2010) 0.80
Helicobacter pylori modulates host cell survival regulation through the serine-threonine kinase, 3-phosphoinositide dependent kinase 1 (PDK-1). BMC Microbiol (2015) 0.79
Blood pressure and stature in Helicobacter pylori positive and negative persons. World J Gastroenterol (2014) 0.78
Serologic host response to Helicobacter pylori and Campylobacter jejuni in socially housed Rhesus macaques (Macaca mulatta). Gut Pathog (2012) 0.75
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science (2000) 7.99
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol (1998) 5.07
Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA (1995) 4.70
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86
Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol (1989) 3.73
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis (1999) 2.88
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Seroepidemiology of Campylobacter pyloridis. N Z Med J (1986) 2.52
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Changes in the epidemiology of dysentery in Poland and the situation in Europe. Arch Immunol Ther Exp (Warsz) (1968) 1.62
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
Dynamics of Helicobacter pylori colonization in relation to the host response. Proc Natl Acad Sci U S A (1999) 1.47
Seroprevalence of Helicobacter pylori in a longitudinal study of New Zealanders at ages 11 and 21. Aust N Z J Med (1998) 1.47
Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol (1999) 1.43
Colonization of Mexican patients by multiple Helicobacter pylori strains with different vacA and cagA genotypes. J Clin Microbiol (1999) 1.39
Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer (1997) 1.38
Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era. Gut (1998) 1.25
Antigenic characterization of Helicobacter pylori strains from different parts of the world. Clin Diagn Lab Immunol (1997) 1.21
Antibody response to Campylobacter pylori in diverse ethnic groups. Scand J Infect Dis (1988) 1.13
Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol (1994) 1.08
Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer (1998) 1.04
The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet (1997) 1.00
Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori. J Clin Microbiol (2001) 0.97
Gastric inflammation is enhanced in children with CagA-positive Helicobacter pylori infection. Pediatr Infect Dis J (1999) 0.88
Helicobacter pylori infection in Desert Storm troops. Clin Infect Dis (1997) 0.84
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Mental disorders and cause-specific mortality. Br J Psychiatry (2001) 2.99
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis (2003) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Prevalence, determinants, and consequences of chronic neck pain in Finland. Am J Epidemiol (1991) 2.59
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Stability of related human and chicken Campylobacter jejuni genotypes after passage through chick intestine studied by pulsed-field gel electrophoresis. Appl Environ Microbiol (1999) 2.38
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Determinants of sciatica and low-back pain. Spine (Phila Pa 1976) (1991) 2.29
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol (1993) 2.22
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr (2005) 2.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect (1999) 2.10
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis (1984) 2.04
From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis (1981) 2.04
Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis (1986) 2.04
Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr (1991) 2.04
Allelic Variation within Helicobacter pylori babA and babB. Infect Immun (2001) 2.02
Outbreaks of Campylobacter enteritis in two extended families: evidence for person-to-person transmission. J Pediatr (1981) 2.01
Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun (1992) 2.01